|
5N85
Structure of RPA70N in complex with PrimPol (fragment 514-525)
Deposited 2017-02-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
514–528(15 aa)
Fragment:UNP Residues 514-528
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293.15 K;0.2 M Ammonium acetate 0.1 M Sodium acetate 4.5 20 % w/v PEG 3350
|
Resolution 2.00 Å
R-free 0.228
|
|
5N8A
Structure of RPA70N in complex with PrimPol (fragment 480-560)
Deposited 2017-02-23
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain X
480–560(81 aa)
Fragment:UNP residues 479-559
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;293.15 K;0.2M imidazole malate, 30% w/v PEG 4000
|
Resolution 1.28 Å
R-free 0.178
|
|
7JK1
Human PrimPol inserting correct dCTP opposite the 8-oxoguanine lesion
Deposited 2020-07-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–354(354 aa)
|
Not recorded
|
DCP 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 1
GOL GLYCEROL × 2
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225-250 mM CaCl2
16-19% PEG 3350
|
Resolution 2.62 Å
R-free 0.286
|
|
7JK1
Human PrimPol inserting correct dCTP opposite the 8-oxoguanine lesion
Deposited 2020-07-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–354(354 aa)
|
Not recorded
|
DCP 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225-250 mM CaCl2
16-19% PEG 3350
|
Resolution 2.62 Å
R-free 0.286
|
|
7JKL
Human PrimPol misinserting dATP opposite the 8-oxoguanine lesion (3'-end base of the primer strand is 2',3'-dideoxy-terminated).
Deposited 2020-07-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225- 250 mM CaCl2, 16 -19% PEG 3350
|
Resolution 2.38 Å
R-free 0.277
|
|
7JKL
Human PrimPol misinserting dATP opposite the 8-oxoguanine lesion (3'-end base of the primer strand is 2',3'-dideoxy-terminated).
Deposited 2020-07-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 2
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225- 250 mM CaCl2, 16 -19% PEG 3350
|
Resolution 2.38 Å
R-free 0.277
|
|
7JKP
Human PrimPol misinserting dATP opposite the 8-oxoguanine lesion
Deposited 2020-07-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225- 250 mM CaCl2
16 -19% PEG 3350
|
Resolution 2.59 Å
R-free 0.307
|
|
7JKP
Human PrimPol misinserting dATP opposite the 8-oxoguanine lesion
Deposited 2020-07-28
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225- 250 mM CaCl2
16 -19% PEG 3350
|
Resolution 2.59 Å
R-free 0.307
|
|
7JL8
Human PrimPol extending from the correct primer base C opposite the 8-oxoguanine lesion
Deposited 2020-07-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 1
GOL GLYCEROL × 2
EDO 1,2-ETHANEDIOL × 1
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225-250 mM CaCl2, 16-19% PEG 3350
|
Resolution 2.10 Å
R-free 0.213
|
|
7JL8
Human PrimPol extending from the correct primer base C opposite the 8-oxoguanine lesion
Deposited 2020-07-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 2
GOL GLYCEROL × 3
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225-250 mM CaCl2, 16-19% PEG 3350
|
Resolution 2.10 Å
R-free 0.213
|
|
7JLG
Human PrimPol extending from the erroneous primer base A opposite the 8-oxoguanine lesion
Deposited 2020-07-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain A
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225-250 mM CaCl2, 16-19% PEG 3350
|
Resolution 2.07 Å
R-free 0.219
|
|
7JLG
Human PrimPol extending from the erroneous primer base A opposite the 8-oxoguanine lesion
Deposited 2020-07-29
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Monomer;Protein × 1
PDB declaration: trimeric
|
Chain B
1–354(354 aa)
|
Not recorded
|
DTP 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE × 1
CA CALCIUM ION × 2
PEG DI(HYDROXYETHYL)ETHER × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;225-250 mM CaCl2, 16-19% PEG 3350
|
Resolution 2.07 Å
R-free 0.219
|